Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable versus oral betamethasone for mandibular third molar surgery
IRCT20180117038415N2Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of betamethasone in impacted third molar (I3M) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Pain intensity, Swelling intensity and 1 more. Started Jun 2018; status: completed.
02
Drugs
betamethasone
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on IRCT20180117038415N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180117038415N2.